19 phenotypes from multigenic genotypes

Allelic Composition Genetic Background	Annotated Term	Reference
Ctnnb1tm1Mmt/Ctnnb1+ Igs2tm1(CAG-Met)Zsu/Igs2+ Tg(Pbsn-cre)4Prb/0 involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2 * FVB/N	increased prostate gland adenocarcinoma incidence	J:284956
	increased prostate intraepithelial neoplasia incidence	J:284956
Igs2em1(Alb-Golm1)Jdon/Igs2+ involves: C57BL/6N	decreased CD8-positive, alpha-beta T cell number	J:306528
	increased incidence of tumors by chemical induction	J:306528
	increased susceptibility to injury	J:306528
Igs2em53(Myh6-cre/ERT2)Gpt/Igs2+ Stx17em1Gpt/Stx17em1Gpt involves: C57BL/6JGpt	abnormal cardiac muscle contractility	J:345305
	abnormal cardiovascular system physiology	J:345305
	abnormal heart morphology	J:345305
	abnormal myocardial fiber morphology	J:345305
	normal growth/size/body region phenotype	J:345305
Igs2tm1(CAG-Met)Zsu/Igs2+ Ptentm1Hwu/Ptentm1Hwu Tg(Pbsn-cre)4Prb/0 involves: 129 * C57BL/6 * DBA/2 * FVB/N	increased carcinoma incidence	J:268934
	increased metastatic potential	J:268934
	increased prostate gland adenocarcinoma incidence	J:268934
	increased prostate gland tumor incidence	J:268934
	increased prostate intraepithelial neoplasia incidence	J:268934
Igs2tm1(CAG-Met)Zsu/Igs2+ Tg(Pbsn-cre)4Prb/0 involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2 * FVB/N	normal endocrine/exocrine gland phenotype	J:268934
	increased prostate intraepithelial neoplasia incidence	J:268934
Igs2tm1(CAG-mt-Keima)Fink/Igs2+ Lamp2tm1Psa/Lamp2tm1Psa involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ	abnormal mitophagy	J:253728
	abnormal myocardial fiber physiology	J:253728
Igs2tm1(CAG-Ptgs2os)Scrp/Igs2tm1(CAG-Ptgs2os)Scrp involves: C57BL/6	abnormal circulating cytokine level	J:325487
	increased circulating interleukin-10 level	J:325487
Igs2tm1(CAG-Ptgs2os)Scrp/Igs2tm1(CAG-Ptgs2os)Scrp Ptgs2osem1Scrp/Ptgs2osem1Scrp involves: C57BL/6	normal immune system phenotype	J:325487